Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Christen

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The Journal of Clinical Investigation|October 1, 1992
Modulation of cisplatin sensitivity and growth rate of an ovarian carcinoma cell line by bombesin and tumor necrosis factor-alphaS Isonishi, A P Jekunen, D K Hom, et al.
Gynecologic Oncology|October 1, 1993
Phase I and pharmacokinetic study of intraperitoneal ormaplatinS C Plaxe, P S Braly, J L Freddo, et al.
Cancer Research|July 1, 1996
Loss of DNA mismatch repair in acquired resistance to cisplatinS Aebi, B Kurdi-Haidar, R Gordon, et al.
The Laryngoscope|June 17, 1998
Observations on control of N2 and N3 neck disease in squamous cell carcinoma of the head and neck by intra-arterial chemoradiationR A Weisman, R D Christen, V E Jones, et al.
Cancer Research|May 15, 1997
In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repairD Fink, H Zheng, S Nebel, et al.
Cancer Metastasis Reviews|June 1, 1994
Signaling and drug sensitivityR D Christen, S Isonishi, J A Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Phase I/pharmacokinetic study of high-dose progesterone and doxorubicinR D Christen, E F McClay, S C Plaxe, et al.
Cancer Chemotherapy and Pharmacology|August 24, 1999
A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxelS Aebi, T W Schnider, G Los, et al.
Cancer Chemotherapy and Pharmacology|May 10, 2000
Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxelM M de las Alas, R D Christen, D P Gately, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Journal of Clinical Investigation|October 1, 1992
Modulation of cisplatin sensitivity and growth rate of an ovarian carcinoma cell line by bombesin and tumor necrosis factor-alphaS Isonishi, A P Jekunen, D K Hom, et al.
Gynecologic Oncology|October 1, 1993
Phase I and pharmacokinetic study of intraperitoneal ormaplatinS C Plaxe, P S Braly, J L Freddo, et al.
Cancer Research|July 1, 1996
Loss of DNA mismatch repair in acquired resistance to cisplatinS Aebi, B Kurdi-Haidar, R Gordon, et al.
The Laryngoscope|June 17, 1998
Observations on control of N2 and N3 neck disease in squamous cell carcinoma of the head and neck by intra-arterial chemoradiationR A Weisman, R D Christen, V E Jones, et al.
Cancer Research|May 15, 1997
In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repairD Fink, H Zheng, S Nebel, et al.
Cancer Metastasis Reviews|June 1, 1994
Signaling and drug sensitivityR D Christen, S Isonishi, J A Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Phase I/pharmacokinetic study of high-dose progesterone and doxorubicinR D Christen, E F McClay, S C Plaxe, et al.
Cancer Chemotherapy and Pharmacology|August 24, 1999
A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxelS Aebi, T W Schnider, G Los, et al.
Cancer Chemotherapy and Pharmacology|May 10, 2000
Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxelM M de las Alas, R D Christen, D P Gately, et al.
Pageof 4